Landscapes / Companies
TaiGen Biotechnology Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 5 in all
Trials
1 active
8 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | 30 Nov 2026soonPhase 1 trial completes | |||
| Next date | 30 Nov 2026 · Phase 1 trial completes | ||||
| Open drug page | |||||
About
- No active trial
- Interferon Alfa-2a, Nemonoxacin, TG-1000, TG-2349
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021